US equities
|
NVDA
$239.89
▲+0.41%
MU
$1,053.97
▼-0.94%
SPCX
$171.83
▲+0.43%
MRVL
$292.06
▲+7.67%
AMD
$655.47
▲+3.75%
INTC
$114.12
▼-1.78%
AVGO
$378.17
▲+4.32%
TSLA
$379.37
▲+0.17%
NVDA
$239.89
▲+0.41%
MU
$1,053.97
▼-0.94%
SPCX
$171.83
▲+0.43%
MRVL
$292.06
▲+7.67%
AMD
$655.47
▲+3.75%
INTC
$114.12
▼-1.78%
AVGO
$378.17
▲+4.32%
TSLA
$379.37
▲+0.17%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Tryptamine Therapeutics
Recent news which mentions Tryptamine Therapeutics
Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials
November 19, 2024
Tickers
NEWS
TYPTF
Tags
News
Benzinga
Phase 2 Clinical Trial
From
Benzinga
Tryp Therapeutics Set To Finalize Merger With Exopharm, Announces Trading Halt Ahead Of ASX Listing
April 25, 2024
Tickers
TRYPF
Tags
M&A
Benzinga
Cannabis
From
Benzinga